BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17320417)

  • 1. Quantitative evaluation of 11C-ABP688 as PET ligand for the measurement of the metabotropic glutamate receptor subtype 5 using autoradiographic studies and a beta-scintillator.
    Wyss MT; Ametamey SM; Treyer V; Bettio A; Blagoev M; Kessler LJ; Burger C; Weber B; Schmidt M; Gasparini F; Buck A
    Neuroimage; 2007 Apr; 35(3):1086-92. PubMed ID: 17320417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the metabotropic glutamate receptor subtype 5 using PET and 11C-ABP688: assessment of methods.
    Treyer V; Streffer J; Wyss MT; Bettio A; Ametamey SM; Fischer U; Schmidt M; Gasparini F; Hock C; Buck A
    J Nucl Med; 2007 Jul; 48(7):1207-15. PubMed ID: 17574984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5.
    Ametamey SM; Kessler LJ; Honer M; Wyss MT; Buck A; Hintermann S; Auberson YP; Gasparini F; Schubiger PA
    J Nucl Med; 2006 Apr; 47(4):698-705. PubMed ID: 16595505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeling and in vitro and in vivo evaluation of [18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5.
    Honer M; Stoffel A; Kessler LJ; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2007 Nov; 34(8):973-80. PubMed ID: 17998101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of [18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5).
    Wanger-Baumann CA; Mu L; Honer M; Belli S; Alf MF; Schubiger PA; Krämer SD; Ametamey SM
    Neuroimage; 2011 Jun; 56(3):984-91. PubMed ID: 21406237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro validation of reference tissue models for the mGluR(5) ligand [(11)C]ABP688.
    Elmenhorst D; Minuzzi L; Aliaga A; Rowley J; Massarweh G; Diksic M; Bauer A; Rosa-Neto P
    J Cereb Blood Flow Metab; 2010 Aug; 30(8):1538-49. PubMed ID: 20531460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding potential of (E)-[¹¹C]ABP688 to metabotropic glutamate receptor subtype 5 is decreased by the inclusion of its ¹¹C-labelled Z-isomer.
    Kawamura K; Yamasaki T; Kumata K; Furutsuka K; Takei M; Wakizaka H; Fujinaga M; Kariya K; Yui J; Hatori A; Xie L; Shimoda Y; Hashimoto H; Hayashi K; Zhang MR
    Nucl Med Biol; 2014 Jan; 41(1):17-23. PubMed ID: 24183615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A first-in-man PET study of [
    Warnock G; Sommerauer M; Mu L; Pla Gonzalez G; Geistlich S; Treyer V; Schibli R; Buck A; Krämer SD; Ametamey SM
    Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):1041-1051. PubMed ID: 29177707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylcysteine- and MK-801-induced changes in glutamate levels do not affect in vivo binding of metabotropic glutamate 5 receptor radioligand 11C-ABP688 in rat brain.
    Wyckhuys T; Verhaeghe J; Wyffels L; Langlois X; Schmidt M; Stroobants S; Staelens S
    J Nucl Med; 2013 Nov; 54(11):1954-61. PubMed ID: 24050937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a bolus/infusion protocol for 11C-ABP688, a PET tracer for mGluR5.
    Burger C; Deschwanden A; Ametamey S; Johayem A; Mancosu B; Wyss M; Hasler G; Buck A
    Nucl Med Biol; 2010 Oct; 37(7):845-51. PubMed ID: 20870160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688.
    Ametamey SM; Treyer V; Streffer J; Wyss MT; Schmidt M; Blagoev M; Hintermann S; Auberson Y; Gasparini F; Fischer UC; Buck A
    J Nucl Med; 2007 Feb; 48(2):247-52. PubMed ID: 17268022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of novel α-fluorinated (E)-3-((6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyl oxime (ABP688) derivatives as metabotropic glutamate receptor subtype 5 PET radiotracers.
    Milicevic Sephton S; Mu L; Schweizer WB; Schibli R; Krämer SD; Ametamey SM
    J Med Chem; 2012 Aug; 55(16):7154-62. PubMed ID: 22822714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, radiolabeling, in vitro and in vivo evaluation of [18F]-FPECMO as a positron emission tomography radioligand for imaging the metabotropic glutamate receptor subtype 5.
    Lucatelli C; Honer M; Salazar JF; Ross TL; Schubiger PA; Ametamey SM
    Nucl Med Biol; 2009 Aug; 36(6):613-22. PubMed ID: 19647167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of four pyridine analogs to characterize 6-OHDA-induced modulation of mGluR5 function in rat brain using microPET studies.
    Zhu A; Wang X; Yu M; Wang JQ; Brownell AL
    J Cereb Blood Flow Metab; 2007 Sep; 27(9):1623-31. PubMed ID: 17299451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation and test-retest studies of [(18)F]PSS232, a novel radioligand for targeting metabotropic glutamate receptor 5 (mGlu5).
    Sephton SM; Herde AM; Mu L; Keller C; Rüdisühli S; Auberson Y; Schibli R; Krämer SD; Ametamey SM
    Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):128-37. PubMed ID: 25139517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of two PET radioligands for the metabotropic glutamate 1 (mGlu1) receptor.
    Huang Y; Narendran R; Bischoff F; Guo N; Bae SA; Hwang DR; Lesage AS; Laruelle M
    Synapse; 2012 Dec; 66(12):1002-14. PubMed ID: 22927303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors: identification, in vitro pharmacology, pharmacokinetic and biodistribution studies.
    Hintermann S; Vranesic I; Allgeier H; Brülisauer A; Hoyer D; Lemaire M; Moenius T; Urwyler S; Whitebread S; Gasparini F; Auberson YP
    Bioorg Med Chem; 2007 Jan; 15(2):903-14. PubMed ID: 17110115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Characterization of mGluR5 Using
    Bertoglio D; Kosten L; Verhaeghe J; Thomae D; Wyffels L; Stroobants S; Wityak J; Dominguez C; Mrzljak L; Staelens S
    J Nucl Med; 2018 Nov; 59(11):1722-1727. PubMed ID: 29794227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test-retest variability of [
    Smart K; Cox SML; Nagano-Saito A; Rosa-Neto P; Leyton M; Benkelfat C
    Synapse; 2018 Sep; 72(9):e22041. PubMed ID: 29935121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2.
    Leurquin-Sterk G; Celen S; Van Laere K; Koole M; Bormans G; Langlois X; Van Hecken A; Te Riele P; Alcázar J; Verbruggen A; de Hoon J; Andrés JI; Schmidt ME
    J Nucl Med; 2017 Jan; 58(1):110-116. PubMed ID: 27469358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.